TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing
14 août 2023 10h25 HE
|
Trxade Health, Inc.
TAMPA, FL, Aug. 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced that it has filed for an extension to file...
TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc.
31 juil. 2023 08h35 HE
|
Trxade Health, Inc.
NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced the closing of the previously announced...
TRxADE HEALTH, Inc. Amends Definitive Merger Agreement with Superlatus, Inc.
14 juil. 2023 16h30 HE
|
Trxade Health, Inc.
NEW YORK, July 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, announced today that it entered into an amended and restated...
TRxADE HEALTH, Inc. Issues Correction to Press Release Announcing its Anticipated Combination with Superlatus, Inc. (Correction Notice)
23 juin 2023 16h40 HE
|
Trxade Health, Inc.
NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ:MEDS) (“TRxADE”), a pharmaceutical exchange platform, today announced a correction to its press release issued on Friday, June...
TRxADE Health, Inc.’s Board of Directors Approves Reverse Stock Split
21 juin 2023 12h36 HE
|
Trxade Health, Inc.
Lutz, Florida, June 21, 2023 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (Nasdaq: MEDS) (the “Company”), today announced that its board of directors has approved a 1-for-15 reverse stock split of its...
TRxADE HEALTH Reports First Quarter Gross Margin of 69% and Q1 2023 Financial Results
15 mai 2023 16h15 HE
|
Trxade Health, Inc.
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, May 15, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or the “Company”), a...
TRxADE HEALTH Reports Third Quarter Gross Margin of 58% and Q3 2022 Financial Results
07 nov. 2022 16h30 HE
|
Trxade Health, Inc.
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, Nov. 07, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or the...
TRxADE HEALTH, INC. Taps Advisory Board Member and Leading Pharmaceutical Industry Expert, Mr. Jeff Newell, For its Board of Directors
03 oct. 2022 09h15 HE
|
Trxade Health, Inc.
TAMPA, FL, Oct. 03, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by...
TRxADE Group Reports Record First Quarter 2021 Financial Results
26 avr. 2021 16h05 HE
|
Trxade Group, Inc.
First Quarter Revenues Increased 39% to $3.1 Million TAMPA, FL, April 26, 2021 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (NASDAQ: MEDS), a health services IT company focused on digitalizing the...